Founders discover cap table problems at the worst possible moments—during a Series A term sheet, in the middle of an acquisition, or when a key employee asks why their options are worth less than expected. By then, fixing them is expensive, time-consuming, and sometimes impossible. A clean cap table, maintained from incorporation through every fundraising round, is one of the most valuable intangible assets your company has. Investors pay more, deals close faster, and employees trust the equity they’re earning.
This guide covers the mechanics of cap table management, the specific mistakes that create problems, and the frameworks to keep your equity structure clean regardless of how fast you’re growing.
Table of Contents
- Cap Table Fundamentals
- Common Mistakes That Destroy Cap Tables
- Equity Instruments Explained
- Option Pool Management
- Managing SAFEs and Convertible Notes
- Cap Table Software and Tools
- When to Hire a Cap Table Lawyer
- Dilution Modeling and Scenario Planning
- Frequently Asked Questions
Cap Table Fundamentals
A cap table (capitalization table) is a complete record of every person or entity that owns equity in your company, how much they own, what they paid for it, and under what terms. It’s simultaneously a legal document, a financial model, and an ongoing governance record.
The cap table starts the moment you incorporate and issue founder shares. Every subsequent action—hiring employees, issuing options, raising money through SAFEs or priced rounds, granting advisor shares—adds a new row. By Series B, a typical cap table has 50-150+ stakeholders across multiple instrument types.
What a cap table tracks:
- Issued and outstanding shares: shares that have been issued and are currently held by someone
- Options granted: the option pool, divided into granted (assigned to specific people) and ungranted (reserved but not yet assigned)
- Warrants: rights to purchase shares at a specified price, often granted to lenders or strategic partners
- SAFEs and convertible notes: instruments that will convert to equity at a future priced round
- Fully diluted shares: the total share count if all options, warrants, SAFEs, and notes converted to equity today
The difference between issued shares and fully diluted shares is critical. Ownership percentages on issued shares look very different from ownership on a fully diluted basis. When VCs talk about ownership, they mean fully diluted. When founders talk about ownership without specifying, they sometimes mean issued—a common source of confusion and conflict.
Authorized vs issued shares:
Your articles of incorporation authorize a total number of shares (typically 10 million for Delaware C-corps at incorporation). Authorized shares don’t have to be issued—you can authorize 10 million and issue 8 million, keeping 2 million in reserve for future issuances. Increasing authorized shares requires shareholder approval and a certificate of amendment, which adds friction. Authorize enough shares at incorporation to cover expected dilution through Series A without amendments.
Par value:
Shares are issued with a par value—a nominal minimum price per share (typically $0.0001 for startups). Par value has no relationship to actual value; it’s a legal formality that affects stock issuance mechanics and state taxes. Always use the lowest permissible par value ($0.0001 or $0.00001) to minimize Delaware franchise taxes and give maximum flexibility in pricing early shares cheaply.
Common Mistakes That Destroy Cap Tables
Most cap table disasters are preventable. They fall into predictable patterns that repeat across thousands of startups.
Issuing shares to co-founders without vesting:
This is the single most expensive cap table mistake. Two founders incorporate, each take 50% of the company outright—no vesting schedule. Six months later, one founder leaves for another opportunity. They walk out the door with 50% of the company, full stop. The remaining founder now runs the company but owns half of it.
Every founder, including CEOs, should be subject to vesting from day one. Standard terms: 4-year vesting with 1-year cliff (nothing vests until month 12, then 25% vests at month 12 and the remaining 75% vests monthly over the following 36 months). The cliff protects against co-founders who leave in the first year before they’ve truly contributed.
Founders who incorporate and immediately begin negotiating co-founder splits without vesting terms are skipping the most important conversation in company formation. Vesting schedules are not a sign of distrust—they’re the mechanism that aligns long-term incentives and protects against the reality that co-founder relationships sometimes don’t work out.
Granting equity verbally:
“I’ll give you 2% of the company” is not a legally binding equity grant. It’s a promise that creates confusion, disputes, and potentially fraudulent transfer claims years later. Every equity grant requires: board approval, a grant agreement signed by both parties, 409A valuation for options, and proper records in the cap table.
Early hires, advisors, and contractors who received verbal equity promises will eventually ask for them in writing. If you can’t produce documentation, you’re either honoring a promise you made informally (expensive and dilutive) or denying it (creating legal exposure and relationship damage). Document everything immediately.
Over-granting advisor equity:
Standard advisor grants range from 0.1% to 0.5% depending on advisor value and stage. Founders who give away 1-2% to advisors who “make introductions and give advice” create cap table bloat that confuses future investors and wastes equity on relationships that rarely deliver proportional value.
Apply the 4-year vest with 1-year cliff to advisors as well. An advisor who stops being useful after 6 months shouldn’t continue vesting—the cliff protects you.
Not filing 83(b) elections:
When founders receive restricted stock (shares subject to vesting and repurchase), an 83(b) election tells the IRS to tax the shares at current (usually near-zero) value rather than at the value when vesting occurs. Without the election, founders pay ordinary income tax on shares as they vest—at the potentially much higher value those shares have reached.
The 83(b) election must be filed within 30 days of receiving shares. There are no exceptions, no extensions, and no fix if you miss it. The tax consequences of a missed 83(b) on a successful startup can be catastrophic—founders receiving millions in equity paying ordinary income rates instead of capital gains rates on vesting events.
Issuing SAFEs without tracking conversion:
SAFEs are quick and cheap to issue—no lawyers required, no pricing round, just sign and close. This convenience leads founders to issue 8-12 SAFEs over 18 months without carefully modeling the dilution at conversion. When the Series A closes, all those SAFEs convert simultaneously, and founders discover they’ve sold 35% of the company in the seed stage through instruments they treated as deferred bookkeeping.
Every SAFE should be modeled at issuance: what percentage does this represent at conversion assuming a range of Series A valuations? A SAFE with a $5M cap issued to a $2M round converts at 40% of the company at conversion if the Series A values the company at $5M—a shock to founders who thought they were issuing small, friendly instruments.
Missing corporate approvals:
Share issuances, option grants, and major contracts require board approval. Founders who issue shares without board resolutions, grant options without proper board authorization, or approve transactions without required shareholder votes create legal exposure that surfaces during due diligence.
The fix is often retroactive consent—getting board and shareholder approval after the fact for actions already taken. This is embarrassing, legally ambiguous in some jurisdictions, and sometimes impossible if shareholders who need to consent have departed. Do it right in real time, every time.
Equity Instruments Explained
A typical Series B cap table contains 6-8 different equity instruments, each with different terms, priorities, and mechanics. Understanding each instrument is essential for accurate cap table management.
| Instrument | Who Receives It | Typical Terms | Tax Treatment |
|---|---|---|---|
| Founder common stock | Co-founders at incorporation | 4-year vest, 1-year cliff | Long-term capital gains (if held 1+ year) |
| ISOs (Incentive Stock Options) | US employees | 4-year vest, 10-year expiration, exercise price = FMV | Favorable: no tax at grant or exercise; LTCG at sale (with AMT risk) |
| NSOs (Non-Qualified Stock Options) | Contractors, advisors, non-US employees | Same mechanics as ISOs | Tax at exercise on spread as ordinary income |
| Restricted Stock Units (RSUs) | Later-stage employees | Vesting schedule, deliver shares upon vest | Ordinary income at delivery |
| SAFEs | Pre-seed/seed investors | Valuation cap and/or discount | Converts to preferred at next priced round |
| Convertible Notes | Bridge investors | Interest rate, maturity, conversion terms | Converts to preferred at next priced round |
| Series Preferred | VC investors in priced rounds | Liquidation preference, anti-dilution, conversion | N/A (investor-side) |
| Warrants | Lenders, strategic partners | Exercise price, expiration date | Tax at exercise on spread |
ISO vs NSO: The employee tax decision:
ISOs (Incentive Stock Options) are the preferred instrument for US employees because of favorable tax treatment: no regular income tax at grant or exercise, only capital gains tax when shares are sold (with a catch—AMT can apply at exercise). ISOs require: employee status (not contractor), exercise price equal to 409A fair market value, and exercise within 90 days of termination.
NSOs (Non-Qualified Stock Options) tax the spread between exercise price and FMV as ordinary income at exercise—potentially a significant cash tax liability when options become valuable. NSOs are used for contractors, advisors, and international employees who don’t qualify for ISOs.
The 90-day post-termination exercise window on ISOs creates a real problem for employees who can’t afford to exercise—they lose options when they leave rather than wait for liquidity. Some companies extend exercise windows to 1-5 years (converting to NSOs, which can have longer windows) to reduce this hardship. This is increasingly common in founder-friendly equity programs.
RSUs in late-stage companies:
RSUs (Restricted Stock Units) deliver shares upon vesting rather than requiring purchase. They’re common at Series C+ companies where option exercise prices are high enough that ISOs lose their value (if the strike price is $50 and current 409A value is $45, options are underwater and useless).
RSUs create tax liability at vesting—employees owe income tax on the full share value when shares deliver, requiring cash or share sale to cover taxes. Many companies implement double-trigger RSUs: shares vest on the schedule but only deliver upon a liquidity event (acquisition or IPO), avoiding the tax liability on illiquid shares.
Option Pool Management
The option pool is the reserved equity used to attract, retain, and reward employees. Managing it well means issuing grants efficiently, refreshing strategically, and never surprising employees or investors with unexpected pool dynamics.
Establishing the initial pool:
At incorporation, most founders establish an option pool of 10-15% of fully diluted shares. This covers early employee grants through seed stage. The pool gets expanded at each VC round—typically to maintain 15-20% of post-round fully diluted shares.
As covered in the term sheet article, pool expansions come out of pre-money valuation by default in investor-friendly term sheets. Negotiate to justify pool size with actual hiring plans rather than accepting arbitrary percentages.
Grant sizing by role and stage:
Standard equity grants vary by role, seniority, and stage. Use these ranges as starting points:
| Role | Seed Stage | Series A | Series B |
|---|---|---|---|
| VP / C-Suite hire | 0.5-1.5% | 0.3-0.8% | 0.1-0.4% |
| Senior Engineer | 0.15-0.4% | 0.1-0.25% | 0.05-0.15% |
| Engineer (mid-level) | 0.05-0.15% | 0.03-0.1% | 0.01-0.05% |
| Sales (Senior AE) | 0.1-0.25% | 0.05-0.15% | 0.02-0.08% |
| Operations / Other | 0.05-0.15% | 0.03-0.08% | 0.01-0.04% |
These are percentage of fully diluted shares—absolute share counts change with each round. The percentages compress at later stages because absolute values increase as the company grows.
Refresh grants:
Employees who joined early will have most of their initial grant vesting by year 3-4. Without refresh grants, they approach a cliff where vesting ends and equity motivation drops. Standard practice: refresh grants at year 2-3 for high performers, sized to maintain meaningful unvested equity at all times.
Refresh grants should be based on performance and market rate for the role, not automatic entitlement. High performers who’ve been with the company since seed and driven meaningful outcomes deserve refresh grants that reflect their contribution. Average performers in roles that have been backfilled don’t.
409A valuations:
Every time you issue options, the exercise price must equal or exceed the current 409A fair market value of common stock. 409A valuations are performed by independent third-party appraisers and are required by IRS regulations.
Get a new 409A whenever: you close a new financing round (which changes the value of the company), 12 months have passed since the last valuation, or a material event occurs (major customer, product launch, executive hire). Issuing options below FMV exposes employees to immediate tax liability and the company to IRS penalties.
409A costs: $1,500-5,000 for early-stage companies, $3,000-10,000 for later stages. Don’t skip them to save money—the IRS penalties for below-market options are far more expensive.
Managing SAFEs and Convertible Notes
SAFEs and convertible notes don’t appear on the cap table as equity—they’re off-balance-sheet obligations that convert to equity at a future priced round. This off-cap-table status leads founders to underestimate their dilutive impact.
Modeling SAFE conversion:
Every SAFE converts based on either a valuation cap (converts at the cap, not the round price, if the round prices above the cap) or a discount (converts at X% below the round price). Post-money SAFEs use post-money cap; pre-money SAFEs use pre-money cap.
The conversion math for a post-money SAFE:
- SAFE amount: $500K
- Post-money cap: $5M
- Implied ownership at conversion: $500K / $5M = 10%
If you raise $2M on SAFEs with various caps averaging $6M, your effective pre-round dilution is approximately 33% before the Series A investor takes their share. This surprises founders who issued SAFEs without running the conversion math.
Build a simple conversion model whenever you’re preparing for a priced round: for each SAFE and note, calculate the shares issued at conversion under different Series A price scenarios. Aggregate the conversions to understand total dilution before negotiating Series A terms.
Pro-rata rights on SAFEs:
YC’s standard SAFE includes optional pro-rata rights—the right for SAFE investors to participate in the next priced round up to their pro-rata share (maintaining their post-conversion ownership percentage). Pro-rata rights on SAFEs are a double-edged sword: they give small investors access to your best rounds (which they appreciate) but can crowd out new investors if the round is oversubscribed.
Negotiate MFN (Most Favored Nation) provisions on SAFE pro-rata rights: if you offer pro-rata to one SAFE investor, all SAFE investors receive the same terms. This prevents a patchwork of different rights across your pre-seed investor base.
Convertible note maturity:
Convertible notes have maturity dates—typically 18-24 months after issuance. If the note matures before you raise a priced round, investors can demand repayment. Cash-strapped startups can’t repay notes and must negotiate extensions or automatic conversion provisions.
Always negotiate: automatic conversion upon maturity (converts to equity at the cap or most recent 409A value) rather than repayment demand. This is increasingly standard but not universal. Notes that can demand repayment at maturity create existential leverage for investors who want better terms.
Cap Table Software and Tools
Managing a cap table in Excel is viable at seed stage with 5-10 stakeholders. By Series A with 40+ stakeholders across multiple instruments, spreadsheets become error-prone and outdated the moment you close a new round.
Carta:
The market standard for US startups. Carta manages equity records, facilitates option exercises, runs 409A valuations, and integrates with payroll systems. Every major VC firm expects portfolio companies to use Carta—they have direct integrations to see portfolio cap tables in real time.
Pricing: free for companies with fewer than 25 stakeholders, then $149-$500/month depending on features and headcount. Well worth it at any stage beyond seed.
Carta’s weaknesses: customer service has declined as they’ve scaled, pricing has increased substantially since 2021, and some founders report feeling locked in with limited data portability. These are legitimate complaints, but the network effect (VCs, lawyers, and employees all know Carta’s interface) makes it the default choice.
Pulley:
Carta competitor focused on earlier-stage companies. Slightly lower pricing, faster customer support, and a cleaner interface for simple cap tables. Doesn’t yet have Carta’s network effects with major VC firms and law firms.
Capdesk (Europe):
European equivalent with stronger support for EU and UK equity programs, including EMI options (UK tax-advantaged employee options) and European ESOP structures that differ from US ISOs.
AngelList:
If you’re running SPV structures or syndicates through AngelList, their cap table management integrates naturally with their investment management tools.
When to Hire a Cap Table Lawyer
Not every cap table question requires a lawyer—many maintenance tasks (adding employees to the option plan, updating records after option exercises) can be handled through cap table software with standard templates. But certain situations require legal expertise that software alone can’t provide.
Situations requiring a startup lawyer:
Incorporation and initial equity structure: getting founder equity splits, vesting terms, and authorized share structure right from day one requires 2-3 hours of lawyer time. The cost ($1,500-3,000) is trivial compared to the problems caused by bad initial structure.
Priced rounds (SAFEs become optional at this point, but any priced equity round requires legal documents—stock purchase agreements, investor rights agreements, voting agreements): expect $8-15K in legal fees for a well-documented seed round, $15-30K for Series A.
Complex equity events: buybacks of founder shares, cancellation of options from terminated employees, modifications to existing equity grants, and equity restructuring (repricing underwater options) all require legal guidance.
M&A and secondary transactions: any share transfer above trivial amounts needs legal oversight for proper ROFR procedures, tax consequences, and transfer mechanics.
Questions you can answer without a lawyer:
- Modeling dilution scenarios using cap table software
- Understanding your current ownership on a fully diluted basis
- Generating standard option grant agreements through Carta using board-approved templates
- Calculating option pool usage and runway
Dilution Modeling and Scenario Planning
Great cap table management isn’t just recording what happened—it’s modeling what will happen across different scenarios before making decisions.
The dilution model every founder needs:
Build a spreadsheet (or use Carta’s modeling tools) that shows your ownership at each future stage: post-Series A, post-Series B, post-Series C, at exit. Include assumptions for: round size, pre-money valuation, option pool expansion at each round, and pro-rata participation by existing investors.
The numbers are sobering but necessary. A founder who starts at 50% ownership typically ends at 15-20% at exit after multiple rounds of dilution. Modeling this trajectory helps founders make informed decisions about how much to raise, at what valuations, and whether to accept terms that increase dilution beyond plan.
Scenario analysis:
Run three scenarios for each fundraising decision:
Base case: raise the planned amount at expected valuation with standard terms. What’s your ownership post-close?
Downside case: raise the same amount at 20-30% lower valuation (down round scenario) with investor-protective terms. What’s your ownership, and is it enough to stay motivated?
Upside case: raise more capital at higher valuation due to competitive term sheet process. Does taking more money at better terms make sense, or does additional dilution offset the benefit?
These scenarios take 30 minutes to model but change how you approach fundraising negotiations. Founders who haven’t modeled downside scenarios make panicked decisions when offers come in below expectations. Founders who’ve run the scenarios know exactly where their walk-away points are.
Modeling exit outcomes:
For each major financing decision, model the exit waterfall under different scenarios: $50M exit, $100M exit, $200M exit, $500M exit. What do you receive in each case after preferences, participation, and waterfall?
This modeling reveals which terms matter most for your specific situation. A 1x vs 2x liquidation preference matters enormously at a $50M exit; it barely matters at a $500M exit. Participating vs non-participating preferred matters at $100M; it’s irrelevant at $1B. Model the scenarios before negotiating—know which battles are worth fighting.
Frequently Asked Questions About Cap Table Management
When should I move from Excel to cap table software?
Move to Carta or equivalent the moment you issue your first options to employees or raise your first institutional round. Pre-option, pre-institutional (just founder shares), a spreadsheet is fine. The moment you have employees with options and need to manage 409A valuations, option exercises, and vesting schedules, software becomes necessary. The cost of doing it right ($150-300/month) is trivial compared to the cost of errors.
How do I fix a messy cap table before fundraising?
Audit everything: reconcile your legal stock ledger against your cap table software against every equity document you’ve ever signed. Identify gaps (missing consents, undocumented promises, unissued shares owed to people). Bring in a startup lawyer to help clean up: get retroactive consents where needed, cancel improperly issued shares through proper board process, document verbal promises or dispute them now rather than during due diligence. Expect to spend $5-15K and 4-6 weeks cleaning up significant cap table problems.
What happens to unvested founder shares in an acquisition?
It depends on your vesting agreement and the acquisition terms. Common outcomes: single-trigger acceleration (all unvested shares vest immediately upon acquisition), double-trigger acceleration (unvested shares vest only if you’re also terminated without cause or resign for good reason post-acquisition), or no acceleration (unvested shares continue vesting according to schedule, converting to acquirer equity). Always negotiate for double-trigger acceleration in your founder employment agreements—it protects you against being fired post-acquisition while still incentivizing you to stay if you want to.
Should all co-founders have equal equity?
Equal splits are common and defensible for co-founders who joined simultaneously, contribute equally, and have comparable risk and opportunity cost. They become problematic when co-founders have very different roles (one full-time CEO, one part-time technical advisor), different risk profiles (one left a $400K job, one kept their job for 6 months), or when co-founder relationships deteriorate.
The most important principle: agree on splits and vesting terms before the company has any value, not after. Negotiating splits after you’ve raised money is orders of magnitude harder than doing it at incorporation when all shares are worth pennies.
Can employees transfer or sell their options before an exit?
Generally no—option agreements restrict transfer and sale. Some mechanisms allow early employees to sell vested options in secondary transactions, but these require company consent, ROFR procedures, and often specific provisions in the option agreement. Companies that want to provide employee liquidity can facilitate tender offers (structured secondary sales) or allow exercise and simultaneous sale in certain circumstances. Without explicit company consent and process, options are illiquid until exit.
What’s the best way to explain equity to early employees?
Use a specific example, not abstract percentages. “You’re receiving options to purchase 50,000 shares. If the company reaches a $100M acquisition valuation, those options could be worth approximately $X” (after explaining the waterfall). Include: how vesting works and what happens if they leave at different points, what the exercise price means and why it matters, and the tax implications of ISOs. Employees who understand their equity stay engaged; those who don’t often feel confused and undervalued even when they hold significant grants.
